224 related articles for article (PubMed ID: 15937624)
1. Intensity of tumor budding and its prognostic implications in invasive colon carcinoma.
Park KJ; Choi HJ; Roh MS; Kwon HC; Kim C
Dis Colon Rectum; 2005 Aug; 48(8):1597-602. PubMed ID: 15937624
[TBL] [Abstract][Full Text] [Related]
2. Tumor budding as an index to identify high-risk patients with stage II colon cancer.
Nakamura T; Mitomi H; Kanazawa H; Ohkura Y; Watanabe M
Dis Colon Rectum; 2008 May; 51(5):568-72. PubMed ID: 18286339
[TBL] [Abstract][Full Text] [Related]
3. Tumor budding and survival after potentially curative resection of node-positive colon cancer.
Sy J; Fung CL; Dent OF; Chapuis PH; Bokey L; Chan C
Dis Colon Rectum; 2010 Mar; 53(3):301-7. PubMed ID: 20173477
[TBL] [Abstract][Full Text] [Related]
4. Identification of patients with high-risk stage II colon cancer for adjuvant therapy.
Quah HM; Chou JF; Gonen M; Shia J; Schrag D; Landmann RG; Guillem JG; Paty PB; Temple LK; Wong WD; Weiser MR
Dis Colon Rectum; 2008 May; 51(5):503-7. PubMed ID: 18322753
[TBL] [Abstract][Full Text] [Related]
5. Prognostic value of intratumoral natural killer cells in gastric carcinoma.
Ishigami S; Natsugoe S; Tokuda K; Nakajo A; Che X; Iwashige H; Aridome K; Hokita S; Aikou T
Cancer; 2000 Feb; 88(3):577-83. PubMed ID: 10649250
[TBL] [Abstract][Full Text] [Related]
6. Budding as a useful prognostic marker in pT3 well- or moderately-differentiated rectal adenocarcinoma.
Okuyama T; Oya M; Ishikawa H
J Surg Oncol; 2003 May; 83(1):42-7. PubMed ID: 12722096
[TBL] [Abstract][Full Text] [Related]
7. Tumor site predicts outcome after radiochemotherapy in squamous-cell carcinoma of the anal region: long-term results of 101 patients.
Grabenbauer GG; Kessler H; Matzel KE; Sauer R; Hohenberger W; Schneider IH
Dis Colon Rectum; 2005 Sep; 48(9):1742-51. PubMed ID: 15991058
[TBL] [Abstract][Full Text] [Related]
8. The role of lymphovascular invasion in predicting the prognosis of clinically localized upper tract urothelial carcinoma (pT1-3cN0M0).
Lin WC; Hu FC; Chung SD; Chueh SC; Pu YS; Huang KH
J Urol; 2008 Sep; 180(3):879-84; discussion 884-5. PubMed ID: 18635224
[TBL] [Abstract][Full Text] [Related]
9. Aerodigestive tract invasion by well-differentiated thyroid carcinoma: diagnosis, management, prognosis, and biology.
McCaffrey JC
Laryngoscope; 2006 Jan; 116(1):1-11. PubMed ID: 16481800
[TBL] [Abstract][Full Text] [Related]
10. Tumour budding at invasive margins and outcome in colorectal cancer.
Kanazawa H; Mitomi H; Nishiyama Y; Kishimoto I; Fukui N; Nakamura T; Watanabe M
Colorectal Dis; 2008 Jan; 10(1):41-7. PubMed ID: 18078460
[TBL] [Abstract][Full Text] [Related]
11. Prognostic significance of metastatic lymph node ratio in node-positive colon carcinoma.
Lee HY; Choi HJ; Park KJ; Shin JS; Kwon HC; Roh MS; Kim C
Ann Surg Oncol; 2007 May; 14(5):1712-7. PubMed ID: 17253102
[TBL] [Abstract][Full Text] [Related]
12. Superficial (pT2a) and deep (pT2b) muscle invasion in pathological staging of bladder cancer following radical cystectomy.
Yu RJ; Stein JP; Cai J; Miranda G; Groshen S; Skinner DG
J Urol; 2006 Aug; 176(2):493-8; discussion 498-9. PubMed ID: 16813876
[TBL] [Abstract][Full Text] [Related]
13. Treatment of carcinoma of the parotid gland: the results of a multicenter study.
Tullio A; Marchetti C; Sesenna E; Brusati R; Cocchi R; Eusebi V
J Oral Maxillofac Surg; 2001 Mar; 59(3):263-70. PubMed ID: 11243607
[TBL] [Abstract][Full Text] [Related]
14. [Postoperative recurrence-related factors of 125 patients with cT1-2N0 squamous cell carcinoma of the oral tongue].
Han JM; Wu GH; Zeng ZY; Chen FJ; Chen WK; Li H; Song M; Sun CZ
Ai Zheng; 2007 Jun; 26(6):661-5. PubMed ID: 17562277
[TBL] [Abstract][Full Text] [Related]
15. Tumor budding as an indicator of isolated tumor cells in lymph nodes from patients with node-negative colorectal cancer.
Park SY; Choe G; Lee HS; Jung SY; Park JG; Kim WH
Dis Colon Rectum; 2005 Feb; 48(2):292-302. PubMed ID: 15616755
[TBL] [Abstract][Full Text] [Related]
16. Tumor budding as a prognostic marker in laryngeal carcinoma.
Sarioglu S; Acara C; Akman FC; Dag N; Ecevit C; Ikiz AO; Cetinayak OH; Ada E;
Pathol Res Pract; 2010 Feb; 206(2):88-92. PubMed ID: 19959297
[TBL] [Abstract][Full Text] [Related]
17. Poorly differentiated thyroid carcinomas defined on the basis of mitosis and necrosis: a clinicopathologic study of 58 patients.
Hiltzik D; Carlson DL; Tuttle RM; Chuai S; Ishill N; Shaha A; Shah JP; Singh B; Ghossein RA
Cancer; 2006 Mar; 106(6):1286-95. PubMed ID: 16470605
[TBL] [Abstract][Full Text] [Related]
18. Clinical significance of microvessel count in patients with metastatic liver cancer originating from colorectal carcinoma.
Nanashima A; Shibata K; Nakayama T; Tobinaga S; Araki M; Kunizaki M; Takeshita H; Hidaka S; Sawai T; Nagayasu T; Yasutake T
Ann Surg Oncol; 2009 Aug; 16(8):2130-7. PubMed ID: 19495885
[TBL] [Abstract][Full Text] [Related]
19. Lymphovascular invasion is independently associated with poor prognosis in patients with localized upper urinary tract urothelial carcinoma treated surgically.
Saito K; Kawakami S; Fujii Y; Sakura M; Masuda H; Kihara K
J Urol; 2007 Dec; 178(6):2291-6; discussion 2296. PubMed ID: 17936818
[TBL] [Abstract][Full Text] [Related]
20. Initial high-grade T1 urothelial cell carcinoma: feasibility and prognostic significance of lamina propria invasion microstaging (T1a/b/c) in BCG-treated and BCG-non-treated patients.
Orsola A; Trias I; Raventós CX; Español I; Cecchini L; Búcar S; Salinas D; Orsola I
Eur Urol; 2005 Aug; 48(2):231-8; discussion 238. PubMed ID: 15963635
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
